Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 102

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 102
---
,506,907 |    |     |                        |  5.8 | % |     |          |  5.5 | % |
| Yechiel Yehoshua Grinfeld             |     |            | 3,230,696 |    |     |                        |  5.3 | % |     |          |  5.1 | % |
| Jose Zajac                            |     |            | 4,751,140 | -6 |     |                        |  7.7 | % |     |          |  7.4 | % |
| Sheldon Perl                          |     |            | 3,562,500 | -7 |     |                        |  5.8 | % |     |          |  5.4 | % |

| * | Less    
 than 1% |

| (1) | Includes                                                                                                                                     
 (i) 2,800,000 common stock, and (ii) 1,490,000 shares of Common Stock issuable upon exercise of vested stock options and options exercisable 
 within 60 days from the date of this Prospectus.                                                                                             |

| (2) | Represents                                                                                                                                     
 shares of Common Stock issuable upon exercise of vested stock options and options exercisable within 60 days from the date of this Prospectus. |

| (3) | Includes                                                                                                        
 5,840,000 common stock. David Safren has the sole voting and investment power over the shares held by SBDHEI LP |

| (4) | Includes                                                                                                                                   
 (i) 3,687,189 common stock, and (ii) 690,000 shares of Common Stock issuable upon exercise of vested stock options and options exercisable 
 within 60 days from the date of this Prospectus.                                                                                           |

| (5) | Includes                                                                                                                                 
 (i) 5,785,410 common stock, and (ii) 1,171,875 shares of Common Stock issuable upon exercise of warrants, exercisable within 60 days     
 from the date of this Prospectus. Yitzchak Rokovsky has the sole voting and investment power over the shares held by Third Eye Investors 
 LLC.                                                                                                                                     |

| (6) | Includes                                                                                                                               
 (i) 3,969,890 common stock, and (ii) 781,250 shares of Common Stock issuable upon exercise of warrants exercisable within 60 days from 
 the date of this Prospect